Bylvay is an oral reversible inhibitor of the ileal bile acid transporter.
Effective screening, diagnosis, and management strategies are needed for patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
In a post-hoc analysis, researchers assessed the effects of lenvatinib compared with sorafenib on health-related quality of life in patients with hepatocellular carcinoma.
Investigators conducted an individual patient data meta-analysis to assess the LSM-VCTE and compare it with the FIB-4 and NFS scores in order to develop diagnostic strategies that could reduce the need for liver biopsies.
Statin use was linked to a lower risk for incident cancer and cancer-related mortality in heart failure.
A team of investigators conducted a prospective cohort study to validate NGAL as a diagnostic and prognostic tool for AKI in cirrhosis within North America.
Although the immune response is slow and the level of protection against infection is modest, mRNA vaccine reduces COVID-19-related hospitalizations and deaths in patients with cirrhosis.
Researchers used real-world data to determine the impact of hepatic fibrosis on the effectiveness of sofosbuvir/velpatasvir treatment in an Asian population with hepatitis C virus infection.
Researchers investigated the underlying mechanisms responsible for insulin resistance in patients with obesity and NAFLD.
The goal of this study was to determine the relationship between subclinical coronary artery disease and the severity of nonalcoholic fatty liver disease.
Researchers evaluated the rates of and factors associated with referral, wait-listing, and receipt of liver allografts.
Health care providers should test liver recipients for hepatitis B virus (HBV) given the slight risk for unexpected donor-derived HBV infection.
Investigators sought to determine if a relationship exists between nonalcoholic fatty liver and adipose tissue, waist-to-height ratio, and body mass index in patients with type 1 diabetes.
Investigators evaluated rates of mortality, hospital utilization, and hospital charges among patients with NASH with and without concurrent kidney failure.
Investigators assessed factors affecting HBsAg seroclearance in individuals with hepatitis B virus infection.
Researchers assessed the cost-effectiveness of universal adult screening for chronic hepatitis B virus infection.
Investigators assessed the effectiveness of hepatitis C virus treatment-as-prevention in a prison setting.
Investigators assessed the safety and efficacy of apatinib in pretreated hepatocellular carcinoma and its effects on overall survival.
A team of researchers sought to compare the seroprotection rate of a hepatitis B virus tri-antigenic vaccine with that of a mono-antigenic vaccine in adults.
Researchers aimed to validate use of the NCYA score and its incorporation of AFP-R in the selection of patients for liver transplant due to HCC recurrence.